Results 241 to 250 of about 43,470 (269)
Some of the next articles are maybe not open access.
Clinics in Laboratory Medicine, 1996
Recent advances in apheresis have emerged in a variety of clinical settings. Improvements in granulocyte and peripheral blood stem cell collection and mobilization, the changing role of intravenous gamma globulin, the importance of patient assessment and selection of replacement fluids, and the progress in both affinity apheresis and photopheresis are ...
N, Bandarenko +3 more
openaire +2 more sources
Recent advances in apheresis have emerged in a variety of clinical settings. Improvements in granulocyte and peripheral blood stem cell collection and mobilization, the changing role of intravenous gamma globulin, the importance of patient assessment and selection of replacement fluids, and the progress in both affinity apheresis and photopheresis are ...
N, Bandarenko +3 more
openaire +2 more sources
Current Opinion in Lipidology, 2016
Purpose of review Currently, different methods for extracorporeal elimination of atherogenic apolipoprotein B100 containing lipoprotein particles are used in clinical practice. Most of them effectively remove both lipoprotein(a) [Lp(a)] and LDL.
Sergei N, Pokrovsky +2 more
openaire +2 more sources
Purpose of review Currently, different methods for extracorporeal elimination of atherogenic apolipoprotein B100 containing lipoprotein particles are used in clinical practice. Most of them effectively remove both lipoprotein(a) [Lp(a)] and LDL.
Sergei N, Pokrovsky +2 more
openaire +2 more sources
Current Treatment Options in Cardiovascular Medicine, 2006
Low-density lipoprotein (LDL)-apheresis is an effective means for acutely lowering plasma cholesterol (LDL reduction > 60%) and reducing cardiovascular events in patients with uncontrolled hypercholesterolemia who are genetically predisposed or resistant to standard therapy.
openaire +2 more sources
Low-density lipoprotein (LDL)-apheresis is an effective means for acutely lowering plasma cholesterol (LDL reduction > 60%) and reducing cardiovascular events in patients with uncontrolled hypercholesterolemia who are genetically predisposed or resistant to standard therapy.
openaire +2 more sources
Disease-a-month : DM, 1984
Therapeutic apheresis is a relatively new modality. Its absolute indications are few and include hyperviscosity syndrome, cryoglobulinemia, thrombotic thrombocytopenic purpura, Goodpasture's syndrome, and life-threatening complications of immunologic disorders refractory to conventional management.
D J, Wallace, J R, Klinenberg
openaire +1 more source
Therapeutic apheresis is a relatively new modality. Its absolute indications are few and include hyperviscosity syndrome, cryoglobulinemia, thrombotic thrombocytopenic purpura, Goodpasture's syndrome, and life-threatening complications of immunologic disorders refractory to conventional management.
D J, Wallace, J R, Klinenberg
openaire +1 more source
Seminars in Dialysis, 2012
AbstractIn general, therapeutic apheresis is a relatively safe procedure with the most commonly seen complications caused by citrate‐induced hypocalcemia and urticarial reactions to the protein‐containing replacement fluid. Depletion coagulopathy and immunoglobulin depletion must be anticipated when albumin is used as the replacement fluid and becomes ...
openaire +2 more sources
AbstractIn general, therapeutic apheresis is a relatively safe procedure with the most commonly seen complications caused by citrate‐induced hypocalcemia and urticarial reactions to the protein‐containing replacement fluid. Depletion coagulopathy and immunoglobulin depletion must be anticipated when albumin is used as the replacement fluid and becomes ...
openaire +2 more sources
Therapeutic Apheresis, 2002
Abstract: Volunteer donor apheresis has evolved from early plasmapheresis procedures that collected single components into technically advanced multicomponent procedures that can produce combinations of red blood cells, platelets, and plasma units. Blood collection and utilization is increasing annually in the United States.
openaire +2 more sources
Abstract: Volunteer donor apheresis has evolved from early plasmapheresis procedures that collected single components into technically advanced multicomponent procedures that can produce combinations of red blood cells, platelets, and plasma units. Blood collection and utilization is increasing annually in the United States.
openaire +2 more sources